Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.

European journal of dermatology : EJD - 1 Jun 2018

Kinoshita Manao, Ogawa Youichi, Takeichi Takuya, Okamoto Takashi, Osada Atsushi, Shimada Shinji, Sugiura Kazumitsu, Akiyama Masashi, Kawamura Tatsuyoshi, Tsukamoto Katsuhiko

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized
Share to Dermatologic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukins

Share to Mutation

Share to Pregnancy

Share to Pregnancy Complications

Share to Psoriasis

Source

Identifiers

PMID: 30105995
DOI: 10.1684/ejd.2018.3259

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.PMID 30105995Read ↗

Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab.Semantic proximity Read ↗

IL36RN mutations underlie impetigo herpetiformis.Semantic proximity Read ↗

Impetigo herpetiformis with IL36RN mutations in a Chinese patient: A founder haplotype of c.115+6T>C in East Asia.Semantic proximity Read ↗

Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases.Semantic proximity Read ↗

Deficiency of the interleukin-36 receptor antagonist dramatically improved by secukinumab.Semantic proximity Read ↗

Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.Semantic proximity Read ↗

Segmental stiff skin syndrome: a novel case with an interleukin-17C mutation successfully treated with secukinumab.Semantic proximity Read ↗

Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.Semantic proximity Read ↗

Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy.Semantic proximity Read ↗

Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation.Semantic proximity Read ↗

Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.Semantic proximity Read ↗

Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.